<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Novartis takes on Cosequin</title><link>/b/veterinary-news/posts/86488</link><description> Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland. 
 Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>